Humanized anti-Tau(pS422) antibodies and methods of use

Invention Grant

US09562091B2 Humanized anti-Tau(pS422) antibodies and methods of use 有权

Title translation: 人源化抗Tau（pS422）抗体及其使用方法

Patent Title: Humanized anti-Tau(pS422) antibodies and methods of use
Patent Title (中): 人源化抗Tau（pS422）抗体及其使用方法
Application No.: US14575067

Application Date: 2014-12-18
Publication No.: US09562091B2

Publication Date: 2017-02-07
Inventor: Fiona Grueninger , Guy Georges , Olaf Mundigl , Michael Schraeml , Bernd Bohrmann , Ulrich Goepfert , Joerg Benz , Hubert Kettenberger
Applicant: Hoffmann-La Roche Inc.
Applicant Address: US NJ Little Falls
Assignee: Hoffmann-La Roche Inc.
Current Assignee: Hoffmann-La Roche Inc.
Current Assignee Address: US NJ Little Falls
Agency: Bryan Cave LLP
Priority: EP13199123 20131220; EP14174047 20140626
Main IPC: C07K16/18
IPC: C07K16/18 ; C07K14/47 ; A61K39/395

Abstract:

The invention provides humanized anti-human Tau(pS422) antibodies and methods of using the same.

Abstract(Chinese):

本发明提供人源化抗人Tau（pS422）抗体及其使用方法。

Public/Granted literature

Information query

Espacenet

IPC分类:

C	化学；冶金
C07	有机化学
C07K	肽（含有β-内酰胺的肽入C07D；在分子中除了形成本身的肽环外不含有任何其他的肽键的环状二肽，如哌嗪-2,5-二酮入C07D；环肽型麦角生物碱入C07D519/02；单细胞蛋白质、酶入C12N；获得肽的基因工程方法入C12N15/00）
C07K16/00	免疫球蛋白，例如，单克隆或多克隆抗体
C07K16/18	.抗来自动物或人的物质